Page last updated: 2024-11-13
lipid iii
Description
Lipid III: from spermatozoa of the fresh water bivalve, Hyriopsis schlegelii; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
alpha-D-FucNAc4-(1->4)-beta-D-ManNAcA-(1->4)-D-GlcNAc-undecaprenyl diphosphate(3-) : An organophosphate oxoanion resulting from deprotonation of the carboxy and phosphate OH groups of alpha-D-FucNAc4-(1->4)-beta-D-ManNAcA-(1->4)-alpha-D-GlcNAc-undecaprenyl diphosphate; major species at pH 7.3. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
Synonyms (13)
| Synonym |
|---|
| eca-lipid iii |
| C55-PP-GLCNAC-MANNACA-FUC4NAC , |
| (enterobacterial common antigen)-undecaprenyl diphosphate |
| n-acetyl-alpha-d-fucosyl-(1->4)-n-acetyl-beta-d-mannosaminouronyl-(1->4)-n-acetyl-alpha-d-glucosaminyl-diphospho-ditrans,octacis-undecaprenol |
| lipid iii |
| mannaca-glcnac-fuc4nac-pp-lipid |
| mannaca-glcnac-fuc4nac-pyrophosphorylundecaprenol |
| undecaprenyl-diphospho n-acetylglucosamine-n-acetylmannosaminuronate-n-acetamido-4,6-dideoxy-d-galactose |
| CHEBI:61496 |
| n-acetyl-glucosaminyl-n-acetyl-mannosaminuronate-4-acetamido-4,6-dideoxy-d-galactose undecaprenyl pyrophosphate(3-) |
| 4-acetamido-4,6-dideoxy-alpha-d-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-d-mannopyranuronosyl-(1->4)-2-acetamido-2-deoxy-1-o-{[({[(2z,6z,10z,14z,18z,22z,26z,30z,34e,38e)-3,7,11,15,19,23,27,31,35,39,43-undecamethyltetratetraconta-2,6,10,14,18,22,26 |
| alpha-d-fucnac4-(1->4)-beta-d-mannaca-(1->4)-d-glcnac-undecaprenyl diphosphate(3-) |
| Q27131108 |
Drug Classes (3)
| Class | Description |
|---|
| organophosphate oxoanion | An organic phosphoric acid derivative in which one or more oxygen atoms of the phosphate group(s) has been deprotonated. |
| monocarboxylic acid anion | A carboxylic acid anion formed when the carboxy group of a monocarboxylic acid is deprotonated. |
| carbohydrate acid derivative anion | A carboxylic acid anion resulting from the deprotonation of the carboxy group of a carbohydrate acid derivative. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (8)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 6 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 25.89
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 25.89 (24.57) | | Research Supply Index | 2.30 (2.92) | | Research Growth Index | 4.32 (4.65) | | Search Engine Demand Index | 37.30 (26.88) | | Search Engine Supply Index | 2.94 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 9 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |